|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000007701 |
|
Date of registration:
|
09/04/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients - Effect of change in medication from AT1 receptor blocker/Ca antagonist concurrent dosage to its combination drug -
|
|
Scientific title:
|
The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients - Effect of change in medication from AT1 receptor blocker/Ca antagonist concurrent dosage to its combination drug - - The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients |
|
Date of first enrolment:
|
2011/07/01 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009054 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Minoru Takemoto |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan
Japan |
|
Telephone:
|
043-222-7171 |
|
Email:
|
minoru.takemoto@faculty.chiba-u.jp |
|
Affiliation:
|
Chiba University Hospital Department of Medicine, Division of Diabetes, Metabolism and Endocrinology |
|
|
Name:
|
Minoru Takemoto |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan
Japan |
|
Telephone:
|
043-222-7171 |
|
Email:
|
minoru.takemoto@faculty.chiba-u.jp |
|
Affiliation:
|
Chiba University Hospital Department of Medicine, Division of Diabetes, Metabolism and Endocrinology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: The exclusion criteria were an age >75 years, current history of myocardial infarction and/or cerebral stroke, renal failure, abnormal liver or muscle enzymes (ALT>100, ALT>100), applied for other clinical trial within 3 months, expectant mother, lactating woman, inappropriate patients judged by the physician in charge
Age minimum:
20years-old
Age maximum:
75years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypertension
|
|
Intervention(s)
|
|
Exchange to combination drug
|
|
Primary Outcome(s)
|
|
Blood pressure
|
|
Source(s) of Monetary Support
|
|
None
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
01/09/2013 |
|
URL:
|
|
|
|